Princeton Innovations Inc

Founded in 2007, Catalent Pharma Solutions is one of the leading providers of advanced technologies to the pharmaceutical, biotechnology and consumer health industries in the world. It offers preclinical support, analytical, clinical manufacturing, packaging, regulatory consulting and drug delivery development services. The organization utilizes the GPEx technology, which provides a range of biologic cell line development services. It also features soft capsules under the Vegicaps and Zydis brands. Catalent Pharma Solutions offers a variety of pharmaceutical product development services. In addition, it produces biological products for preclinical and clinical studies. The organization's packaging solutions include DelPouch and DelStrip, which are unit-dose delivery systems for lotions, creams, ointments and thin film strips.

Gemini Laboratories, a subsidiary of Amneal Pharmaceuticals based in Bridgewater, NJ, is committed to creating essential medicines and advancing healthcare through a diverse portfolio of approximately 280 generic and specialty pharmaceuticals. The company prioritizes innovation and accessibility, developing first-to-file and first-to-market complex medicines while supporting patients and communities in navigating conditions such as Parkinson's disease. With a strong focus on patient care, Gemini Laboratories actively contributes to public health initiatives, including increasing access to critical medications like Naloxone Nasal Spray. Their culture emphasizes collaboration and dedication, driving efforts to make healthy possible for patients and their families. Generated from the website

Amarin Pharma Inc is a global pharmaceutical company dedicated to combating cardiovascular disease, aiming to prevent it from becoming a leading cause of death worldwide. With a focus on innovative solutions, Amarin works to make a positive impact on cardiovascular health through its research, development, and distribution of cutting-edge products. Driven by a bold vision, Amarin Corporation leads the way in cardiovascular health management, striving to provide better care for individuals affected by cardiovascular disease. With a commitment to collaboration and leveraging its core strengths, Amarin seeks to create value and forge partnerships to further its mission of stopping cardiovascular disease in its tracks.Generated from the website